h.agyeman

TL2 Moderator · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 24 April 2025 · last posted 20h

83Posts here

0Topics

0Solutions

1.9kLikes received

1.1kLikes given

22Badges

238Days visited

4.7kPosts read

Recent activity

Full stream

Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #98 · Compounds › Retatrutide · 27 Jul 2026 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
Why the timeline is on the right and not the left — what changed since Replied, post #82 · Meta › Site feedback · 26 Jul 2026 · 32 likes Picking up post #79: that is the part I would want checked first. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #80 · Outcomes › Progress reports · 24 Jul 2026 · 4 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Prescription portability between countries Replied, post #101 · Access › International · 16 Jul 2026 · 0 likes Picking up post #98: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
How to ask a question when you cannot say why you are asking it Replied, post #42 · Start Here › How to Ask · 16 Jul 2026 · 5 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #11 · Clinical › Bloodwork · 10 Jul 2026 · 10 likes Coming back to post #9, because the follow-up matters more than the original answer. TSH and free hormones: TSH is a reasonable screening test but does not tell you…
Deletion sequences: expected mass shifts by residue — the long version Replied, post #7 · Analytics › Impurities & related substances · 10 Jul 2026 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #100 · Devices › Syringes & needles · 9 Jul 2026 · 1 like Coming back to post #98, because the follow-up matters more than the original answer. Reading units correctly: look at the marking from the side, not from above or…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #105 · Start Here › How to Ask · 7 Jul 2026 · 1 like Worth separating two things that post #101 runs together. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #67 · Evidence › Journal club · 29 Jun 2026 · 32 likes On post #63 — agreed on the reasoning, with one qualification. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #89 · Evidence › Journal club · 12 Jun 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Racemisation and why it is invisible to a mass measurement Replied, post #60 · Analytics › Impurities & related substances · 12 Jun 2026 · 9 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…